Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 13/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 15/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carene SCHEMBL19922327 | 1.00 | CNR1 (0.37) | CNR1TSHRMAPK1CNR2 | |
| Carene SCHEMBL112444 | 1.00 | CNR1 (0.37) | CNR1TSHRMAPK1CNR2 | |
| Carene SCHEMBL16268963 | 1.00 | CNR1 (0.37) | CNR1TSHRMAPK1CNR2 | |
| Carene SCHEMBL31500923 | 1.00 | CNR1 (0.37) | CNR1TSHRMAPK1CNR2 | |
| 2-Carene SCHEMBL8815400 | 0.81 | CNR2 (0.32) | CNR1CNR2 | |
| (-)-Limonene SCHEMBL7088792 | 0.78 | LMNA (0.69) | TSHRMAPK1CNR2 | |
| Camphor SCHEMBL6535476 | 0.76 | ALDH1A1 (0.61) | — | |
| SCHEMBL15130293 | 0.76 | CNR1 (0.41) | CNR1CNR2 | |
| Carene SCHEMBL5043252 | 0.75 | PTGS2 (0.34) | CNR1CNR2 | |
| Dexborneol SCHEMBL2905504 | 0.75 | KMT2A (0.34) | MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250295123-A1 | Arthropod Control Compositions | FIRMENICH & CIE (CH) | 2025-09-25 | — | — | US | claimed |
| CN-119999678-A | Transverse pit pin cutting bark beetle attractant | 云南省林业和草原科学院 | 2025-05-16 | — | — | CN | claimed |
| EP-4527191-A1 | UREASE INHIBITORS | Symrise AG (DE) | 2025-03-26 | — | — | EP | claimed |
| EP-4426116-A1 | ARTHROPOD CONTROL COMPOSITIONS | Firmenich SA (CH) | 2024-09-11 | — | — | EP | claimed |
| US-20230247992-A1 | ARTHROPOD CONTROL COMPOSITION | FIRMENICH & CIE (CH) | 2023-08-10 | — | — | US | claimed |
| WO-2023117960-A1 | ARTHROPOD CONTROL COMPOSITIONS | FIRMENICH SA (CH) | 2023-06-29 | — | — | WO | claimed |
| EP-4181681-A1 | ARTHROPOD CONTROL COMPOSITION | Firmenich SA (CH) | 2023-05-24 | — | — | EP | claimed |
| CN-114513960-A | Antimicrobial composition for animal feed | 塔明克私人有限公司 | 2022-05-17 | — | — | CN | claimed |
| WO-2022013204-A1 | ARTHROPOD CONTROL COMPOSITION | FIRMENICH SA (CH) | 2022-01-20 | — | — | WO | claimed |
| EP-4581007-B1 | DIMETHYLBICYCLOHEPTENYL AND DIMETHYLBICYCLOHEPTANYL DERIVATIVES AND THEIR USE AS ODORANTS | GIVAUDAN SA (CH) | 2026-05-27 | — | — | EP | disclosed |
| CN-122056932-A | A Chinese medicinal essential oil composition for treating alopecia, and its preparation method | 赣江新区智药善和科技有限公司 | 2026-05-19 | — | — | CN | disclosed |
| US-20260078080-A1 | DIMETHYLBICYCLOHEPTENYL AND DIMETHYLBICYCLOHEPTANYL DERIVATIVES AND THEIR USE AS ODORANTS | GIVAUDAN SA (CH) | 2026-03-19 | — | — | US | disclosed |
| EP-4702036-A1 | METHOD OF PRODUCING TERPENES | Nicoventures Trading Limited (GB) | 2026-03-04 | — | — | EP | disclosed |
| US-12502369-B2 | Methods of cancer treatment | K-GEN THERAPEUTICS, INC. | 2025-12-23 | — | — | US | disclosed |
| US-20110251426-A1 | SCREENING FOR SOLID FORMS BY ULTRASOUND CRYSTALLIZATION AND COCRYSTALLIZATION USING ULTRASOUND | S.S.C.I., INC. (US) | 2011-10-13 | — | — | US | disclosed |
| EP-2292585-A1 | Screening for solid forms by ultrasound crystallization and cocrystallization using ultrasound | APTUIT (KANSAS CITY), LLC (US) | 2011-03-09 | — | — | EP | disclosed |
| US-20090281195-A1 | NOVEL COCRYSTALLIZATION | S.S.C.I., INC. (US) | 2009-11-12 | — | — | US | disclosed |
| US-7452555-B2 | Cocrystallization | S.S.C.I., INC. (US) | 2008-11-18 | — | — | US | disclosed |
| US-20070287194-A1 | Screening For Solid Forms By Ultrasound Crystallization And Cocrystallization Using Ultrasound | S.S.C.I., INC | 2007-12-13 | — | — | US | disclosed |
| US-20070088508-A1 | Cocrystallization methods | APTUIT (WEST LAFAYETTE), LLC | 2007-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12502369-B2 | Methods of cancer treatment | PRKCH, PRKCB, PRKCA | CNR1 4017/4885TSHR 2631/4885MAPK1 2973/4885 |
| US-20260078080-A1 | DIMETHYLBICYCLOHEPTENYL AND DIMETHYLBICYCLOHEPTANYL DERIVATIVES AND THEIR USE AS ODORANTS | GALR1, GALK1, GALR2 | CNR1 341/4885TSHR 2548/4885MAPK1 216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.